Brooks Automation (NASDAQ: BRKS) reported Q4 EPS of $0.40, versus $0.35 reported last year. Revenue for the quarter came in at $208 million versus the consensus estimate of $206 million.

Management Comments

"Our 2018 fiscal year was strong from start to finish and has charted a new path with transformative M&A agreements that are reshaping the company," commented Steve Schwartz, CEO of Brooks Automation. "The acquisition of GENEWIZ, which we completed last week, is expanding our reach in sample services to thousands of additional customers, supported by a highly talented global team. Further, we signed an agreement in August to sell our Semiconductor Cryogenics business and expect to complete the sale during our second fiscal quarter of 2019. We believe these transactions strengthen our growth portfolio and extend our position as the leading provider of life science sample services. Meanwhile we continued our strong operating performance in the semiconductor business and delivered yet another consecutive growth quarter in life sciences, yielding a 20% top-line growth for the year."

GUIDANCE:

Brooks Automation sees Q1 2019 EPS of $0.10-$0.14, versus the consensus of $0.00. Brooks Automation sees Q1 2019 revenue of $170-180 million, versus the consensus of $214.37 million.

For earnings history and earnings-related data on Brooks Automation (BRKS) click here.